Sideways and almost ready.Price consolidated sideways for a few days, and it wants to break higher to retest previous highs.
1.02USD
105.50 MUSD
482.38 MUSD
89.26 M
About Corcept Therapeutics Incorporated
Sector
CEO
Joseph K. Belanoff
Headquarters
Menlo Park
Website
Employees (FY)
352
Founded
1998
ISIN
US2183521028
FIGI
BBG000BKJG33
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. It engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.
LONG CORTIf the market pulls back, this will too. But we are at a level of support, so low volatility entry will allow us to manage the risk on this trade better. Breaking that support, we would close the trade.
CORT, MACD Histogram just turned positiveThis is a Bullish indicator signaling CORT's price could rise from here. Traders may explore going long the stock or buying call options. Tickeron's A.I. dvisor identified 48 similar cases where CORT's MACD histogram became positive, and 42 of them led to successful outcomes. Odds of Success: 88%. C
U.S. Patent Trial and Appeals Board Affirms ValidityU.S. Patent Trial and Appeals Board Affirms Validity of All Claims of Corcept’s U.S. Patent No.10,195,214
announced today that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has issued a decision upholding the validity of all claims of U.S. Patent No. 10,195,214, “
CORT Potential Long: fundamentals and shortOnly an idea.
Industry ranked 37 in biotech. 3b market cap.
Big buy happened.
Current ratio of debt coverage is 10. :)
Modest growth 6% of ROE Q/Q: :| compared to others
Current volume trend is above normal, but 20day volume is below. so wait to see.
The dip is coming and then a run up.
Double bott
PAY to CORCEPT THERAPEUTICS DailyHey traders, CORCEPT THERAPEUTICS is in a fake bearish move with low sell volume executed and a water carrier with strong shadow of buyers. In the TIMEFRAME M1 we can see a mini marubozu bull with a low purchase volume. Strong potential for breakout the price of going on its last precedent higher af
CORT, Aroon Indicator entered an Uptrend on Oct 23, 2020.Over the last three days, Tickeron A.I.dvisor has detected that CORT's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red line stays below 30, this is an indicator that the stock could be poised for a strong Uptrend.
Some penny stock porn on #CORT $CORT Pennant pattern . Some penny stock porn on #CORT $CORT Pennant pattern .
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CORT is 23.39 USD — it has increased by 1.04% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Corcept Therapeutics Incorporated stocks are traded under the ticker CORT.
Corcept Therapeutics Incorporated is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Corcept Therapeutics Incorporated has a max estimate of 61.00 USD and a min estimate of 35.00 USD.
CORT earnings for the last quarter are 0.28 USD whereas the estimation was 0.22 USD which accounts for 28.24% surprise. Estimated earnings for the next quarter are 0.26 USD. See more details about Corcept Therapeutics Incorporated earnings.
Corcept Therapeutics Incorporated revenue for the last quarter amounts to 123.60 M USD despite the estimated figure of 119.71 M USD. In the next quarter revenue is expected to reach 129.27 M USD.
Yes, you can track Corcept Therapeutics Incorporated financials in yearly and quarterly reports right on TradingView.
Like other stocks, CORT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Corcept Therapeutics Incorporated stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 352.00 employees. See our rating of the largest employees — is Corcept Therapeutics Incorporated on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Corcept Therapeutics Incorporated EBITDA is 109.59 M USD, and current EBITDA margin is 22.46%. See more stats in Corcept Therapeutics Incorporated financial statements.